Cargando…
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration
Dry eye disease (DED) is one of the most common eye diseases caused by multiple factors. Rebamipide, which is currently used to treat peptic ulcer disease, was shown to enhance secretory function and modulate inflammation in animal disease models. Considering the pathophysiology of DED, SA001 was de...
Autores principales: | Bae, Sungyeun, Huh, Ki Young, Oh, Jaeseong, Yu, Kyung-Sang, Kim, Anhye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862565/ https://www.ncbi.nlm.nih.gov/pubmed/36678630 http://dx.doi.org/10.3390/ph16010132 |
Ejemplares similares
-
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects
por: Jiang, Xu, et al.
Publicado: (2023) -
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects
por: Park, Min Young, et al.
Publicado: (2023) -
Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs
por: Bae, Sungyeun, et al.
Publicado: (2022) -
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers
por: Chung, Woo Kyung, et al.
Publicado: (2022) -
Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima, Tomoyuki, et al.
Publicado: (2012)